Zero‑Shot Design of Drug‑Binding Proteins Demonstrates High Accuracy and Affinity

Date:

By pairing two neural networks in an iterative optimization algorithm, researchers have shown that small‑molecule binding proteins can be designed from scratch with high accuracy, strong affinity and impressive success rates, suggesting new possibilities for drug delivery and sequestration.

A study published online June 24, 2026 in Nature describes a “zero‑shot” approach that combines a protein‑structure prediction network with a ligand‑binding predictor in a loop of selection and expansion. The method generates candidate proteins, evaluates their predicted binding to target small molecules, and iteratively refines the designs without relying on existing protein templates.

In benchmark tests, the newly designed proteins bound a range of drug‑like compounds with nanomolar affinities, rivaling or exceeding those of naturally occurring binders. The success rate—measured as the proportion of designs that achieved measurable binding—was reported to be markedly higher than previous computational protein‑design pipelines.

The authors highlight several potential applications, including creating bespoke carriers for therapeutic agents, developing sequestration tools to neutralize toxins, and accelerating the discovery of protein‑based diagnostics. Because the workflow does not require prior structural data for a target, it could be applied to emerging drugs and small molecules where conventional design methods fall short.

Analysis: The study represents a significant advance in computational protein engineering by integrating deep‑learning models for structure and function in a closed‑loop system. If the reported affinities and success rates hold up in broader experimental validation, the technique could shorten development timelines for protein therapeutics and enable rapid response to novel drug targets. However, real‑world deployment will require extensive testing for stability, immunogenicity and manufacturability—factors not addressed in the initial publication.

Sources
– Nature, “Zero‑shot design of drug‑binding proteins via neural iterative selection‑expansion,” published online 24 June 2026, https://www.nature.com/articles/s41586-026-10670-w


Source: Nature – Original article

Corrections

If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.

Story synopsis gathered from: Nature — source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

Breaking Finlay Tarling Dies Following Accident During Tour of Portugal

British cycling has suffered a significant loss following the death of 19-year-old cyclist Finlay Tarling, who died after a serious accident during the eighth stage of the Tour of Portugal. The fatality was confirmed on Friday through official statements released…

Breaking Trump Dismisses Concerns Over Record Nine Month Navy Deployment

President Donald Trump has rejected concerns regarding the extended deployment of sailors aboard the aircraft carrier USS Abraham Lincoln, asserting that their time in operation was "not nearly long enough." The comments follow reports that the crew has been deployed…

Breaking Dominic Sessa Stars in Anthony Bourdain Biopic Focusing on Early Career

A new cinematic portrait of Anthony Bourdain has arrived, eschewing the traditional chronological biopic structure to focus exclusively on the formative, chaotic years of the late chef’s youth. Starring Dominic Sessa, the film centers on a pivotal summer in Bourdain's…

Breaking The Great Stink of 2026? Hot, Dry Summer Leaves London Holding Its Nose

London is facing a widespread environmental crisis as a prolonged period of record-breaking heat and severe drought has triggered the release of putrid sewer odors across the capital. The surge in noxious gases, emanating from the city's aging drainage systems,…